The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury

Yashashree Joshi(German Center for Neurodegenerative Diseases), Marília Grando Sória(Hertie Institute for Clinical Brain Research), Giorgia Quadrato(Hertie Institute for Clinical Brain Research), Gizem Inak(Hertie Institute for Clinical Brain Research), Luming Zhou(Hertie Institute for Clinical Brain Research), Arnau Hervera(Imperial College London), Khizr I. Rathore(Hertie Institute for Clinical Brain Research), Mohamed Y. El‐Naggar(Hertie Institute for Clinical Brain Research), Magali Cucchiarini(Saarland University), Jeanne Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Radhika Puttagunta(Hertie Institute for Clinical Brain Research), Simone Di Giovanni(Hertie Institute for Clinical Brain Research)
Brain
May 16, 2015
Cited by 64Open Access
Full Text

Abstract

Regeneration of injured central nervous system axons is highly restricted, causing neurological impairment. To date, although the lack of intrinsic regenerative potential is well described, a key regulatory molecular mechanism for the enhancement of both axonal regrowth and functional recovery after central nervous system injury remains elusive. While ubiquitin ligases coordinate neuronal morphogenesis and connectivity during development as well as after axonal injury, their role specifically in axonal regeneration is unknown. Following a bioinformatics network analysis combining ubiquitin ligases with previously defined axonal regenerative proteins, we found a triad composed of the ubiquitin ligases MDM4, MDM2 and the transcription factor p53 (encoded by TP53) as a putative central signalling complex restricting the regeneration program. Indeed, conditional deletion of MDM4 or pharmacological inhibition of MDM2/p53 interaction in the eye and spinal cord promote axonal regeneration and sprouting of the optic nerve after crush and of supraspinal tracts after spinal cord injury. The double conditional deletion of MDM4-p53 as well as MDM2 inhibition in p53-deficient mice blocks this regenerative phenotype, showing its dependence upon p53. Genome-wide gene expression analysis from ex vivo fluorescence-activated cell sorting in MDM4-deficient retinal ganglion cells identifies the downstream target IGF1R, whose activity and expression was found to be required for the regeneration elicited by MDM4 deletion. Importantly, we demonstrate that pharmacological enhancement of the MDM2/p53-IGF1R axis enhances axonal sprouting as well as functional recovery after spinal cord injury. Thus, our results show MDM4-MDM2/p53-IGF1R as an original regulatory mechanism for CNS regeneration and offer novel targets to enhance neurological recovery.media-1vid110.1093/brain/awv125_video_abstractawv125_video_abstract.


Related Papers

No related papers found

Powered by citation graph analysis